CM
PRQR icon

Caption Management’s ProQR Therapeutics PRQR Stock Holding History

Caption Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-60,000
Closed -$55K – 1751
2022
Q1 		$55K Buy
+60,000
New +$201K ﹤0.01% 1357

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Caption Management's PRQR Position: Q2 2022 in Review

Caption Management sold out of ProQR Therapeutics (PRQR) in Q2 2022, closing a stake of 60,000 shares — an estimated $55K sold.

Caption Management first reported a position in PRQR in Q1 2022 and held it in 1 quarter. The position peaked at $55K in Q1 2022. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2022.

  • Caption Management reported no remaining ProQR Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Caption Management sold 60,000 ProQR Therapeutics shares in Q2 2022, an estimated $55K.
  • Caption Management first reported a position in ProQR Therapeutics in Q1 2022 and held it in 1 quarter.
  • Caption Management's ProQR Therapeutics position peaked at $55K in Q1 2022.
  • 51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.